Your browser doesn't support javascript.
loading
Low prevalence of clarithromycin-resistant Helicobacter pylori isolates with A2143G point mutation in the 23S rRNA gene in North India.
Gehlot, Valentina; Mahant, Shweta; Mukhopadhyay, Asish Kumar; Das, Kunal; Alam, Jawed; Ghosh, Prachetash; Das, Rajashree.
Afiliação
  • Gehlot V; Amity Institute of Biotechnology, Amity University, Noida, Uttar Pradesh, India.
  • Mahant S; Amity Institute of Biotechnology, Amity University, Noida, Uttar Pradesh, India.
  • Mukhopadhyay AK; National Institute of Cholera and Enteric Diseases, Kolkata, West Bengal, India.
  • Das K; Yashoda Superspecialty Hospital, Ghaziabad, Uttar Pradesh, India; Max Superspecialty Hospital, Vaishali, Ghaziabad, NCR, India.
  • Alam J; National Institute of Cholera and Enteric Diseases, Kolkata, West Bengal, India.
  • Ghosh P; National Institute of Cholera and Enteric Diseases, Kolkata, West Bengal, India.
  • Das R; Amity Institute of Biotechnology, Amity University, Noida, Uttar Pradesh, India. Electronic address: rajashreepatra79@yahoo.co.in.
J Glob Antimicrob Resist ; 6: 39-43, 2016 09.
Article em En | MEDLINE | ID: mdl-27530837
ABSTRACT
Resistance of Helicobacter pylori to clarithromycin is associated with a single base substitution in the 23S rRNA gene. In this study, clarithromycin-resistant H. pylori isolates were analysed for the presence of 23S rRNA gene mutations. H. pylori were isolated from 68 patients suffering from various gastroduodenal diseases in North India. Minimum inhibitory concentrations (MICs) were determined by the agar dilution method, and point mutations in clarithromycin-resistant strains were identified by PCR-restriction fragment length polymorphism (PCR-RFLP) and DNA sequencing. Clarithromycin resistance was observed in 11.8% (8/68) of the H. pylori isolates in North India. The A2143G point mutation in the 23S rRNA gene was found in 87.5% (7/8) of the clarithromycin-resistant strains, and the A2142G mutation in association with the T2182C mutation was found in 12.5% (1/8). In conclusion, the continued high prevalence of clarithromycin-sensitive H. pylori strains (88.2%) observed in this study allows the use of the triple-therapy regimen for the treatment of H. pylori infection in this region. Surveillance studies need to be conducted at regular intervals for clarithromycin resistance in the population. To our knowledge, this is the first study in India to report that point mutations at position A2143G and at A2142G in association with T2182C are associated with clarithromycin resistance, confirming reports from other parts of the world.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: RNA Ribossômico 23S / Helicobacter pylori / Claritromicina / Farmacorresistência Bacteriana Idioma: En Ano de publicação: 2016 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: RNA Ribossômico 23S / Helicobacter pylori / Claritromicina / Farmacorresistência Bacteriana Idioma: En Ano de publicação: 2016 Tipo de documento: Article